371 related articles for article (PubMed ID: 16860179)
1. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
2. Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications.
Dormuth CR; Maclure M; Glynn RJ; Neumann P; Brookhart AM; Schneeweiss S
Clin Ther; 2008; 30 Spec No(Spec No):1038-50. PubMed ID: 18640478
[TBL] [Abstract][Full Text] [Related]
3. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
4. Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.
Dormuth CR; Neumann P; Maclure M; Glynn RJ; Schneeweiss S
Med Care; 2009 May; 47(5):508-16. PubMed ID: 19365295
[TBL] [Abstract][Full Text] [Related]
5. Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma.
Kozyrskyj AL; Mustard CA; Cheang MS; Simons FE
CMAJ; 2001 Oct; 165(7):897-902. PubMed ID: 11599328
[TBL] [Abstract][Full Text] [Related]
6. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period.
Krigsman K; Moen J; Nilsson JL; Ring L
J Clin Pharm Ther; 2007 Dec; 32(6):603-11. PubMed ID: 18021338
[TBL] [Abstract][Full Text] [Related]
7. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
[TBL] [Abstract][Full Text] [Related]
10. The use of inhaled and related respiratory medications in Christchurch rest homes.
Botting C; Sutherland M; Wells E; Town I; Sainsbury R; Toop L
N Z Med J; 2003 Dec; 116(1187):U709. PubMed ID: 14752537
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
12. Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1992-2002.
Molfino NA
Medicina (B Aires); 2004; 64(5):407-12. PubMed ID: 15560541
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
14. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
15. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
18. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
[TBL] [Abstract][Full Text] [Related]
19. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
20. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
Li X; Guh D; Lacaille D; Esdaile J; Anis AH
Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]